• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Large Pharma


31.465 EUR 0.095 0.30%

As of 02:16:01 ET on 08/29/2014.

Snapshot for Eisai Co Ltd (EII)

Open: 31.425 Day's Range: 31.354 - 31.505 Volume: 0
Previous Close: 31.370 52wk Range: 26.596 - 32.025 1-Yr Rtn: +7.36%

Stock Chart for EII

No chart data available.
  • EII:GR 31.465
  • 1D
  • 1M
  • 1Y
Interactive EII Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for EII

Current P/E Ratio (ttm) -
Estimated P/E(03/2015) 37.5764
Relative P/E vs. DAX -
Earnings Per Share (JPY) (ttm) -
Est. EPS (JPY) (03/2015) 114.5070
Est. PEG Ratio 4.1567
Market Cap (M EUR) 9,331.48
Shares Outstanding (M) 296.57
30 Day Average Volume 10
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 3.49%
Cash Dividend (JPY) 70.0000
Dividend Ex-Date 09/26/2014
5 Year Dividend Growth 2.33%
Next Earnings Announcement 10/31/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for EII

  • Revenue
  • Net Income (M/JPY)
  • Profit Margin (%)

Company Profile & Key Executives for EII

Eisai Co., Ltd. produces prescription drugs and medical equipment and sells mainly to sales agents and subsidiaries. Through its subsidiary, Sanko Junyaku, the Company produces and sells diagnostic drugs. Eisai also markets its products through related companies in the US, Europe, and Asia. The Company also manufactures and sells foods, livestock feeds, chemical, and agrochemicals.

Hideaki MatsuiDirectorNobuo DeguchiDirector
Noboru NaoeDirectorHaruo NaitoRep Corporate Officer/CEO
More Company Profile & Key Executives for EII

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil